Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2003
06/03/2003US6573384 Process for production of indole derivatives and intermediates therefor
06/03/2003US6573382 Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
06/03/2003US6573293 Anticancer agents
06/03/2003US6573289 Naphthalene derivatives, their production and use
06/03/2003US6573279 Isoquinoline derivatives or salts thereof
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573275 Insecticidal compositions comprising and to methods of combatting and controlling insect pests therewith.
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573267 Central nervous system disorders
06/03/2003US6573266 Piperazine derivatives and their use as anti-inflammatory agents
06/03/2003US6573262 Compounds for treating mammals infected with HIV virus
06/03/2003US6573260 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
06/03/2003CA2273446C Piperidones
06/03/2003CA2223625C Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044014A1 Indole-2-carboxamides as factor xa inhibitors
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003043993A1 5-phenylpyrimidines, agents comprising the same, method for production and use thereof
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043987A2 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
05/30/2003WO2003043985A1 Heterocyclic compounds and methods of use
05/30/2003WO2003043983A1 Piperazine derivatives destabilising androgen receptors
05/30/2003WO2003043982A1 Derivatives of andrimide and moiramide b having antibacterial properties
05/30/2003WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
05/30/2003WO2003043980A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
05/30/2003WO2003043735A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
05/30/2003WO2003043591A1 Use of at least one abl, kit and/or platelet-derived growth factor receptor tyrosine kinases inhibitor for treating hair depigmentation
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2003005824B1 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
05/30/2003WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
05/30/2003WO2003002106A3 Use of tyrosine kinase inhibitions for treating allergic diseases
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003WO2002036116A9 Tripeptidyl peptidase inhibitors
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467749A1 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/29/2003US20030100770 D-proline derivatives
05/29/2003US20030100769 Such s 2-(6-chloro-3-pyridyl)-2-imidazoline which has good affinity for and activate alpha-4-beta-2-nicotinic acetyl-choline receptors; for treatment and prevention of neuro-degenerative disorders (Alzheimer's/Parkinson's disease)
05/29/2003US20030100765 Process for preparing heterocyclo-alkysulfonyl pyrazole derivatives
05/29/2003US20030100757 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100753 Process for the production of quinazolines
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/29/2003US20030100597 Novel indole derivatives and their use as medicaments
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100582 Benzimidazole compounds for regulating IgE
05/29/2003US20030100581 Norastemizole polymorphs
05/29/2003US20030100579 Useful for treatment of diseases such as obsessive compulsive disorder, panic attacks, anxiety, sexual dysfunction, eating disorders, obesity, addictive disorders
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100558 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure
05/29/2003US20030100554 Pyrazole derivatives
05/29/2003US20030100549 Inhibitors of c-Jun N-terminal kinases (JNK)
05/29/2003US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors
05/29/2003US20030100539 Metabotropic glutamate receptors (mGluR); treating fragile X, autism, mental retardation, schizophrenia and Down's Syndrome
05/29/2003US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay
05/29/2003US20030100018 Mass-based encoding and qualitative analysis of combinatorial libraries
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1314733A1 Indole-2-carboxamides as factor Xa inhibitors
05/28/2003EP1314732A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314731A2 Substituted pyrimidine compounds and their use
05/28/2003EP1314728A1 Pyridyl and pyrimidinyl imines as intermediates for imidazole derivatives
05/28/2003EP1314726A1 Novel ester or amide derivatives
05/28/2003EP1313726A1 Quinoline derivatives having vegf inhibiting activity
05/28/2003EP1313725A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313713A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313709A1 Pyrazolyl biphenyl carboxamides
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313704A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1313426A4 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1313426A2 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1222305A4 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1155001A4 Isoquinoline derivatives and isoquinoline combinatorial libraries
05/28/2003EP1068198B1 5-heteroaryl substituted indoles
05/28/2003EP1065205B1 Heteroaromatic derivatives
05/28/2003EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof
05/28/2003EP0966464B1 Substituted 2,4-diaminopyrimidines
05/28/2003EP0850222B1 Piperazine derivatives and process for the preparation thereof
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003CN1420883A N-aryl-(homopiperazinyl) cyclohexyl amines as 5-HT transporters
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420880A Substd. N-Benzyl-indol-3-yl glyoxylic acid derivs. having anti-tumoral effect
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420873A Substd. phenyluracils
05/28/2003CN1420776A Inhibition of cyclooxygenase-2 activity
05/28/2003CN1420114A 2,3-disubstd. -4(3H)-quinazolones
05/28/2003CN1109685C Substd. benzocycloheptapyridine derivs. useful for inhibition of farnesyl protein transferase
05/28/2003CN1109684C Novel compound form
05/28/2003CN1109676C Substd. aminophenyluracils as herbicides and insecticides
05/28/2003CN1109675C Arylpyrimidine derivs.
1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 1080